Equity by Design: Utility of a Metrics Framework and Metrics To Evaluate Progress on Diversity, Equity, and Inclusion in Clinical Research


Released on: June 14, 2022

Published in: BIO International Convention, San Diego CA

Dr. Willyanne DeCormier Plosky, Program Manager at the MRCT Center, presented on this panel, which was organized by the MRCT Center to discuss the origins, development, structure, and lessons learned from pilot testing of the Equity by Design (EbD) in Clinical Research Metrics Framework. The panel was moderated by Camelia Thompson (BIO), and also included Neha Londono (Seagen Inc.); and Inez Ruiz-White (Otsuka Pharmaceuticals) as speakers. See the recording here.